{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:01:20Z","timestamp":1767772880320,"version":"3.45.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-024-11090-6","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T21:24:38Z","timestamp":1737062678000},"page":"5661-5677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrating network pharmacology with molecular docking and dynamics to uncover therapeutic targets and signaling mechanisms of vitamin D3 in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"11090_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo Y, Darweesh S, Llibre-Guerra J et al (2024) The epidemiology of Parkinson\u2019s disease. Lancet 403:283\u2013292. https:\/\/doi.org\/10.1016\/S0140-6736(23)01419-8","journal-title":"Lancet"},{"key":"11090_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M et al (2023) Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Pathol 18:95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annu Rev Pathol"},{"key":"11090_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JPD-212922","volume":"12","author":"BR De Miranda","year":"2022","unstructured":"De Miranda BR, Goldman SM, Miller GW et al (2022) Preventing Parkinson\u2019s disease: an environmental agenda. J Parkinsons Dis 12:45\u201368. https:\/\/doi.org\/10.3233\/JPD-212922","journal-title":"J Parkinsons Dis"},{"key":"11090_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"P Dion\u00edsio","year":"2021","unstructured":"Dion\u00edsio P, Amaral J, Rodrigues C (2021) Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Res Rev 67:101263. https:\/\/doi.org\/10.1016\/j.arr.2021.101263","journal-title":"Ageing Res Rev"},{"key":"11090_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A et al (2020) Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics. Nat Rev Neurol 16:303\u2013318. https:\/\/doi.org\/10.1038\/s41582-020-0344-4","journal-title":"Nat Rev Neurol"},{"key":"11090_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"key":"11090_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010716-104624","volume":"57","author":"P Hutson","year":"2017","unstructured":"Hutson P, Clark J, Cross A (2017) CNS target identification and validation: avoiding the valley of death or naive optimism? Annu Rev Pharmacol Toxicol 57:171\u2013187. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010716-104624","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11090_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53\u201358. https:\/\/doi.org\/10.1210\/jc.2010-2704","journal-title":"J Clin Endocrinol Metab"},{"key":"11090_CR9","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/ajcn\/80.3.752","volume":"80","author":"HA Bischoff-Ferrari","year":"2004","unstructured":"Bischoff-Ferrari HA, Dietrich T, Orav EJ et al (2004) Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged\u2265 60 y. Am J Clin Nutr 80:752\u2013758. https:\/\/doi.org\/10.1093\/ajcn\/80.3.752","journal-title":"Am J Clin Nutr"},{"key":"11090_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.beem.2011.05.009","volume":"25","author":"LR Harms","year":"2011","unstructured":"Harms LR, Burne TH, Eyles DW et al (2011) Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab 25:657\u2013669. https:\/\/doi.org\/10.1016\/j.beem.2011.05.009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"11090_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/s1043-2760(01)00547-1","volume":"13","author":"E Garcion","year":"2002","unstructured":"Garcion E, Wion-Barbot N, Montero-Menei CN et al (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13:100\u2013105. https:\/\/doi.org\/10.1016\/s1043-2760(01)00547-1","journal-title":"Trends Endocrinol Metab"},{"key":"11090_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/cns.13801","volume":"28","author":"S Mazzetti","year":"2022","unstructured":"Mazzetti S, Barichella M, Giampietro F et al (2022) Astrocytes expressing Vitamin D-activating enzyme identify Parkinson\u2019s disease. CNS Neurosci Ther 28:703\u2013713. https:\/\/doi.org\/10.1111\/cns.13801","journal-title":"CNS Neurosci Ther"},{"key":"11090_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114718","volume":"162","author":"MJ Anwar","year":"2023","unstructured":"Anwar MJ, Alenezi SK, Alhowail AH (2023) Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders. Biomed Pharmacother 162:114718. https:\/\/doi.org\/10.1016\/j.biopha.2023.114718","journal-title":"Biomed Pharmacother"},{"key":"11090_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","volume":"29","author":"DW Eyles","year":"2005","unstructured":"Eyles DW, Smith S, Kinobe R et al (2005) Distribution of the vitamin D receptor and 1\u03b1-hydroxylase in human brain. J Chem Neuroanat 29:21\u201330","journal-title":"J Chem Neuroanat"},{"key":"11090_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuroscience.2013.01.035","volume":"236","author":"X Cui","year":"2013","unstructured":"Cui X, Pelekanos M, Liu PY et al (2013) The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 236:77\u201387. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.01.035","journal-title":"Neuroscience"},{"key":"11090_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/j.1460-9568.2006.04637.x","volume":"23","author":"MA Gates","year":"2006","unstructured":"Gates MA, Torres EM, White A et al (2006) Re-examining the ontogeny of substantia nigra dopamine neurons. Eur J Neurosci 23:1384\u20131390. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04637.x","journal-title":"Eur J Neurosci"},{"key":"11090_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/mds.25405","volume":"28","author":"AL Peterson","year":"2013","unstructured":"Peterson AL, Mancini M, Horak FB (2013) The relationship between balance control and vitamin D in Parkinson\u2019s disease-a pilot study. Mov Disord 28:1133\u20131137. https:\/\/doi.org\/10.1002\/mds.25405","journal-title":"Mov Disord"},{"key":"11090_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JPD-171122","volume":"7","author":"I Sleeman","year":"2017","unstructured":"Sleeman I, Aspray T, Lawson R et al (2017) The role of vitamin D in disease progression in early Parkinson\u2019s disease. J Parkinsons Dis 7:669\u2013675. https:\/\/doi.org\/10.3233\/JPD-171122","journal-title":"J Parkinsons Dis"},{"key":"11090_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","volume":"97","author":"M Suzuki","year":"2013","unstructured":"Suzuki M, Yoshioka M, Hashimoto M et al (2013) Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr 97:1004\u20131013. https:\/\/doi.org\/10.3945\/ajcn.112.051664","journal-title":"Am J Clin Nutr"},{"key":"11090_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/oem.2010.057448","volume":"68","author":"L Kenborg","year":"2011","unstructured":"Kenborg L, Lassen CF, Ritz B et al (2011) Outdoor work and risk for Parkinson\u2019s disease: a population-based case-control study. Occup Environ Med 68:273\u2013278. https:\/\/doi.org\/10.1136\/oem.2010.057448","journal-title":"Occup Environ Med"},{"key":"11090_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40035-020-00213-2","volume":"9","author":"L Lv","year":"2020","unstructured":"Lv L, Tan X, Peng X et al (2020) The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson\u2019s disease. Transl Neurodegener 9:34. https:\/\/doi.org\/10.1186\/s40035-020-00213-2","journal-title":"Transl Neurodegener"},{"key":"11090_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117606","volume":"428","author":"C Agliardi","year":"2021","unstructured":"Agliardi C, Guerini FR, Zanzottera M et al (2021) The VDR FokI (rs2228570) polymorphism is involved in Parkinson\u2019s disease. J Neurol Sci 428:117606. https:\/\/doi.org\/10.1016\/j.jns.2021.117606","journal-title":"J Neurol Sci"},{"key":"11090_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2016.09.013","volume":"370","author":"NM Gatto","year":"2016","unstructured":"Gatto NM, Paul KC, Sinsheimer JS et al (2016) Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson\u2019s disease. J Neurol Sci 370:100\u2013106. https:\/\/doi.org\/10.1016\/j.jns.2016.09.013","journal-title":"J Neurol Sci"},{"key":"11090_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3233\/JPD-130206","volume":"3","author":"AL Peterson","year":"2013","unstructured":"Peterson AL, Murchison C, Zabetian C et al (2013) Memory, mood, and vitamin D in persons with Parkinson\u2019s disease. J Parkinsons Dis 3:547\u2013555. https:\/\/doi.org\/10.3233\/JPD-130206","journal-title":"J Parkinsons Dis"},{"key":"11090_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fneur.2020.00454","volume":"11","author":"ME Fullard","year":"2020","unstructured":"Fullard ME, Duda JE (2020) A review of the relationship between vitamin D and Parkinson disease symptoms. Front Neurol 11:454. https:\/\/doi.org\/10.3389\/fneur.2020.00454","journal-title":"Front Neurol"},{"key":"11090_CR26","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL (2008) Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 4:682\u2013690. https:\/\/doi.org\/10.1038\/nchembio.118","journal-title":"Nat Chem Biol"},{"key":"11090_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1758-2946-6-13","volume":"6","author":"J Ru","year":"2014","unstructured":"Ru J, Li P, Wang J et al (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6:13. https:\/\/doi.org\/10.1186\/1758-2946-6-13","journal-title":"J Cheminform"},{"key":"11090_CR28","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C, Wilson M, Klinger CM et al (2024) DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res 52:D1265\u2013D1275. https:\/\/doi.org\/10.1093\/nar\/gkad976","journal-title":"Nucleic Acids Res"},{"key":"11090_CR29","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47:W357\u2013W364. https:\/\/doi.org\/10.1093\/nar\/gkz382","journal-title":"Nucleic Acids Res"},{"key":"11090_CR30","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J et al (2020) The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48:D845\u2013D855. https:\/\/doi.org\/10.1093\/nar\/gkz1021","journal-title":"Nucleic Acids Res"},{"key":"11090_CR31","doi-asserted-by":"publisher","first-page":"bax028","DOI":"10.1093\/database\/bax028","volume":"2017","author":"S Fishilevich","year":"2017","unstructured":"Fishilevich S, Nudel R, Rappaport N et al (2017) GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database 2017:bax028. https:\/\/doi.org\/10.1093\/database\/bax028","journal-title":"Database"},{"key":"11090_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.763777","volume":"14","author":"K Tiklova","year":"2021","unstructured":"Tiklova K, Gillberg L, Volakakis N et al (2021) Disease duration influences gene expression in neuromelanin-positive cells from Parkinson\u2019s disease patients. Front Mol Neurosci 14:763777. https:\/\/doi.org\/10.3389\/fnmol.2021.763777","journal-title":"Front Mol Neurosci"},{"key":"11090_CR33","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s10571-021-01146-8","volume":"42","author":"A Zaccaria","year":"2022","unstructured":"Zaccaria A, Antinori P, Licker V et al (2022) Multiomic analyses of dopaminergic neurons isolated from human substantia nigra in Parkinson\u2019s disease: a descriptive and exploratory study. Cell Mol Neurobiol 42:2805\u20132818. https:\/\/doi.org\/10.1007\/s10571-021-01146-8","journal-title":"Cell Mol Neurobiol"},{"key":"11090_CR34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath T, Abdulraouf A, Burris SJ et al (2022) Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci 25:588\u2013595. https:\/\/doi.org\/10.1038\/s41593-022-01061-1","journal-title":"Nat Neurosci"},{"key":"11090_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471250953.bi0813s47","volume":"47","author":"G Su","year":"2014","unstructured":"Su G, Morris JH, Demchak B et al (2014) Biological network exploration with Cytoscape 3. Curr Protoc Bioinform 47:1\u201324. https:\/\/doi.org\/10.1002\/0471250953.bi0813s47","journal-title":"Curr Protoc Bioinform"},{"issue":"4","key":"11090_CR36","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH et al (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8(4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11","journal-title":"BMC Syst Biol"},{"key":"11090_CR37","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377","journal-title":"Nucleic Acids Res"},{"key":"11090_CR38","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G, Soufan O, Ewald J et al (2019) NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res 47:W234\u2013W241. https:\/\/doi.org\/10.1093\/nar\/gkz240","journal-title":"Nucleic Acids Res"},{"key":"11090_CR39","doi-asserted-by":"publisher","first-page":"D87","DOI":"10.1093\/nar\/gkz1001","volume":"48","author":"O Fornes","year":"2020","unstructured":"Fornes O, Castro-Mondragon JA, Khan A et al (2020) JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 48:D87\u2013D92. https:\/\/doi.org\/10.1093\/nar\/gkz1001","journal-title":"Nucleic Acids Res"},{"key":"11090_CR40","doi-asserted-by":"publisher","first-page":"D148","DOI":"10.1093\/nar\/gkz896","volume":"48","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lin YC, Li J et al (2020) miRTarBase 2020: updates to the experimentally validated microRNA-target interaction database. Nucleic Acids Res 48:D148\u2013D154. https:\/\/doi.org\/10.1093\/nar\/gkz896","journal-title":"Nucleic Acids Res"},{"key":"11090_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA et al (2011) Open babel: an open chemical toolbox. J Cheminform 3:33. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminform"},{"key":"11090_CR42","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF et al (2021) AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model 61:3891\u20133898. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203","journal-title":"J Chem Inf Model"},{"key":"11090_CR43","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.str.2016.11.012","volume":"24","author":"S Yuan","year":"2016","unstructured":"Yuan S, Chan HCS, Filipek S et al (2016) PyMOL and inkscape bridge the data and the data visualization. Structure 24:2041\u20132042. https:\/\/doi.org\/10.1016\/j.str.2016.11.012","journal-title":"Structure"},{"key":"11090_CR44","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Simon-Sanchez","year":"2009","unstructured":"Simon-Sanchez J, Schulte C, Bras JM et al (2009) Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat Genet 41:1308\u20131312. https:\/\/doi.org\/10.1038\/ng.487","journal-title":"Nat Genet"},{"key":"11090_CR45","doi-asserted-by":"publisher","first-page":"fcaa119","DOI":"10.1093\/braincomms\/fcaa119","volume":"2","author":"BM Jacobs","year":"2020","unstructured":"Jacobs BM, Taylor T, Awad A et al (2020) Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis. Brain Commun 2:fcaa119. https:\/\/doi.org\/10.1093\/braincomms\/fcaa119","journal-title":"Brain Commun"},{"key":"11090_CR46","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1093\/brain\/awad295","volume":"147","author":"Q Yin","year":"2024","unstructured":"Yin Q, Zhu L (2024) Does co-localization analysis reinforce the results of Mendelian randomization? Brain 147:e7\u2013e8. https:\/\/doi.org\/10.1093\/brain\/awad295","journal-title":"Brain"},{"key":"11090_CR47","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/molecules23081899","volume":"23","author":"T Pantsar","year":"2018","unstructured":"Pantsar T, Poso A (2018) Binding affinity via docking: fact and fiction. Molecules 23:1899. https:\/\/doi.org\/10.3390\/molecules23081899","journal-title":"Molecules"},{"key":"11090_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM et al (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet"},{"key":"11090_CR49","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mds.29778","volume":"39","author":"N Veronese","year":"2024","unstructured":"Veronese N, Nova A, Fazia T et al (2024) Contribution of nutritional, lifestyle, and metabolic risk factors to Parkinson\u2019s disease. Mov Disord 39:1203\u20131212. https:\/\/doi.org\/10.1002\/mds.29778","journal-title":"Mov Disord"},{"key":"11090_CR50","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","volume":"16","author":"MG Sanchez","year":"2010","unstructured":"Sanchez MG, Bourque M, Morissette M et al (2010) Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther 16:e43\u2013e71. https:\/\/doi.org\/10.1111\/j.1755-5949.2010.00163.x","journal-title":"CNS Neurosci Ther"},{"key":"11090_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/brainsci8080154","volume":"8","author":"P Pinares-Garcia","year":"2018","unstructured":"Pinares-Garcia P, Stratikopoulos M, Zagato A et al (2018) Sex: a significant risk factor for neurodevelopmental and neurodegenerative disorders. Brain Sci 8:154. https:\/\/doi.org\/10.3390\/brainsci8080154","journal-title":"Brain Sci"},{"key":"11090_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107201","volume":"204","author":"W He","year":"2024","unstructured":"He W, Zhang S, Qi Z et al (2024) Unveiling the potential of estrogen: exploring its role in neuropsychiatric disorders and exercise intervention. Pharmacol Res 204:107201. https:\/\/doi.org\/10.1016\/j.phrs.2024.107201","journal-title":"Pharmacol Res"},{"key":"11090_CR53","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/mds.28760","volume":"36","author":"CDJ Kusters","year":"2021","unstructured":"Kusters CDJ, Paul KC, Duarte Folle A et al (2021) Increased menopausal age reduces the risk of Parkinson\u2019s disease: a mendelian randomization approach. Mov Disord 36:2264\u20132272. https:\/\/doi.org\/10.1002\/mds.28760","journal-title":"Mov Disord"},{"key":"11090_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jns.2012.05.026","volume":"319","author":"R Yadav","year":"2012","unstructured":"Yadav R, Shukla G, Goyal V et al (2012) A case control study of women with Parkinson\u2019s disease and their fertility characteristics. J Neurol Sci 319:135\u2013138. https:\/\/doi.org\/10.1016\/j.jns.2012.05.026","journal-title":"J Neurol Sci"},{"key":"11090_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11910-021-01115-0","volume":"21","author":"HJ Roeder","year":"2021","unstructured":"Roeder HJ, Leira EC (2021) Effects of the menstrual cycle on neurological disorders. Curr Neurol Neurosci Rep 21:34. https:\/\/doi.org\/10.1007\/s11910-021-01115-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"11090_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104693","volume":"155","author":"M Wu","year":"2020","unstructured":"Wu M, Li M, Yuan J et al (2020) Postmenopausal hormone therapy and Alzheimer\u2019s disease, dementia, and Parkinson\u2019s disease: a systematic review and time-response meta-analysis. Pharmacol Res 155:104693. https:\/\/doi.org\/10.1016\/j.phrs.2020.104693","journal-title":"Pharmacol Res"},{"key":"11090_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105479","volume":"156","author":"M Bourque","year":"2024","unstructured":"Bourque M, Morissette M, Di Paolo T (2024) Neuroactive steroids and Parkinson\u2019s disease: review of human and animal studies. Neurosci Biobehav Rev 156:105479. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105479","journal-title":"Neurosci Biobehav Rev"},{"key":"11090_CR58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bpc.2012.09.002","volume":"170","author":"S Chakraborty","year":"2012","unstructured":"Chakraborty S, Willett H, Biswas PK (2012) Insight into estrogen receptor beta-beta and alpha-beta homo- and heterodimerization: a combined molecular dynamics and sequence analysis study. Biophys Chem 170:42\u201350. https:\/\/doi.org\/10.1016\/j.bpc.2012.09.002","journal-title":"Biophys Chem"},{"key":"11090_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4014","volume":"42","author":"E Rymbai","year":"2024","unstructured":"Rymbai E, Sugumar D, Chakkittukandiyil A et al (2024) Molecular insights into the potential effects of selective estrogen receptor beta agonists in Alzheimer\u2019s and Parkinson\u2019s diseases. Cell Biochem Funct 42:e4014. https:\/\/doi.org\/10.1002\/cbf.4014","journal-title":"Cell Biochem Funct"},{"key":"11090_CR60","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.addr.2010.08.001","volume":"62","author":"EK Shanle","year":"2010","unstructured":"Shanle EK, Xu W (2010) Selectively targeting estrogen receptors for cancer treatment. Adv Drug Deliv Rev 62:1265\u20131276. https:\/\/doi.org\/10.1016\/j.addr.2010.08.001","journal-title":"Adv Drug Deliv Rev"},{"key":"11090_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fncel.2016.00149","volume":"10","author":"M Sarvari","year":"2016","unstructured":"Sarvari M, Kallo I, Hrabovszky E et al (2016) Long-term estrogen receptor beta agonist treatment modifies the hippocampal transcriptome in middle-aged ovariectomized rats. Front Cell Neurosci 10:149. https:\/\/doi.org\/10.3389\/fncel.2016.00149","journal-title":"Front Cell Neurosci"},{"key":"11090_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122144","volume":"333","author":"E Rymbai","year":"2023","unstructured":"Rymbai E, Sugumar D, Chakkittukandiyil A et al (2023) The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson\u2019s disease models. Life Sci 333:122144. https:\/\/doi.org\/10.1016\/j.lfs.2023.122144","journal-title":"Life Sci"},{"key":"11090_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114279","volume":"182","author":"CH Song","year":"2020","unstructured":"Song CH, Kim N, Hee Nam R et al (2020) 17beta-Estradiol strongly inhibits azoxymethane\/dextran sulfate sodium-induced colorectal cancer development in Nrf2 knockout male mice. Biochem Pharmacol 182:114279. https:\/\/doi.org\/10.1016\/j.bcp.2020.114279","journal-title":"Biochem Pharmacol"},{"key":"11090_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","volume":"1662","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Rabiee N, Zabihnejad S et al (2017) Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: possible involvement of ERbeta\/Nrf2\/HO-1 signaling. Brain Res 1662:23\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2017.02.021","journal-title":"Brain Res"},{"key":"11090_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101756","volume":"82","author":"M George","year":"2022","unstructured":"George M, Tharakan M, Culberson J et al (2022) Role of Nrf2 in aging, Alzheimer\u2019s and other neurodegenerative diseases. Ageing Res Rev 82:101756. https:\/\/doi.org\/10.1016\/j.arr.2022.101756","journal-title":"Ageing Res Rev"},{"key":"11090_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1756-6606-2-5","volume":"2","author":"V Cullen","year":"2009","unstructured":"Cullen V, Lindfors M, Ng J et al (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2:5. https:\/\/doi.org\/10.1186\/1756-6606-2-5","journal-title":"Mol Brain"},{"key":"11090_CR67","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.bbadis.2014.04.008","volume":"1842","author":"K Nakaso","year":"2014","unstructured":"Nakaso K, Tajima N, Horikoshi Y et al (2014) The estrogen receptor beta-PI3K\/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson\u2019s disease model. Biochim Biophys Acta 1842:1303\u20131312. https:\/\/doi.org\/10.1016\/j.bbadis.2014.04.008","journal-title":"Biochim Biophys Acta"},{"key":"11090_CR68","doi-asserted-by":"publisher","first-page":"9439","DOI":"10.1523\/JNEUROSCI.1443-06.2006","volume":"26","author":"P Mannella","year":"2006","unstructured":"Mannella P, Brinton RD (2006) Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1\/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J Neurosci 26:9439\u20139447. https:\/\/doi.org\/10.1523\/JNEUROSCI.1443-06.2006","journal-title":"J Neurosci"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11090-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11090-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11090-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:29:05Z","timestamp":1763728145000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11090-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11090"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11090-6","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}